October 29, 2013 | Hong Kong communication and industrial mogul Li Ka-shing is investing $6 million in Israeli startup MeMed, “Calcalist” reports. This is Li’s second investment in Israeli biomed and 20th in Israel overall. MeMed develops technology for disease diagnosis, which enables doctor to differentiate between different types of bacteria and between bacteria and viruses, thus helping them to decide which antibiotics to prescribe.
Related posts
Israeli Pineapple-Based Burn Therapy Treating Injured US Troops
October 02, 2023
AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023
Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023
Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Facebook comments